HWAM
Hennion & Walsh Asset Management’s Anavex Life Sciences AVXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-59,550
| Closed | -$390K | – | 819 |
|
|
2023
Q3 | $390K | Sell |
59,550
-11,757
| -16% | -$77K | 0.02% | 592 |
|
|
2023
Q2 | $580K | Buy |
71,307
+749
| +1% | +$6.09K | 0.03% | 473 |
|
|
2023
Q1 | $605K | Sell |
70,558
-1,658
| -2% | -$14.2K | 0.04% | 467 |
|
|
2022
Q4 | $669K | Buy |
72,216
+5,757
| +9% | +$53.3K | 0.04% | 429 |
|
|
2022
Q3 | $686K | Sell |
66,459
-2,229
| -3% | -$23K | 0.05% | 418 |
|
|
2022
Q2 | $688K | Buy |
68,688
+6,629
| +11% | +$66.4K | 0.04% | 411 |
|
|
2022
Q1 | $764K | Buy |
62,059
+24,503
| +65% | +$302K | 0.04% | 408 |
|
|
2021
Q4 | $651K | Buy |
+37,556
| New | +$651K | 0.03% | 473 |
|